WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications.

CoapTech has closed a Series B investment of $7 million led by Hunniwell. The funds will be used to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement.